查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1772514

美国生物处理容器市场规模、份额、趋势分析报告：按产品、应用、最终用途、细分市场预测，2025-2033 年

U.S. Bioprocess Containers Market Size, Share & Trends Analysis Report By Product (2D U.S. Bioprocess Containers, 3D U.S. Bioprocess Containers), By Application (Upstream Process, Downstream Process), By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国生物处理容器市场摘要

美国生物处理容器市场规模预计在 2024 年为 10.9 亿美元，预计到 2033 年将达到 65.5 亿美元，2025 年至 2033 年的复合年增长率为 22.1%。该行业的发展受到生物製药製造中一次性技术的日益普及以及对生技药品和疫苗生产灵活、可扩展解决方案的需求不断增长的推动。

此外，强劲的研发投入和支持性法律规范将进一步推动市场成长。生物製药产业的快速成长是市场成长的主要驱动力，尤其是对单株抗体、细胞和基因疗法以及疫苗日益增长的需求。一次性生物製程容器 (SUBC) 是现代生物製造的理想选择，因为它们灵活、经济高效，并且与传统不銹钢系统相比，污染风险更低。例如，在新冠疫情期间，mRNA 疫苗生产的激增凸显了对可扩展、一次性解决方案的需求，辉瑞和 Moderna 等公司严重依赖一次性技术来加快生产进度。

另一个关键驱动因素是向个人化医疗和小批量生产的转变，这有利于一次性系统，因为它们具有适应性强且营运成本低。细胞和基因疗法（例如CAR-T细胞疗法）需要专门的无菌环境，而SUBC无需经过大量清洗和验证即可实现。赛默飞世尔科技和赛多利斯等公司正在扩展其可客製化生物处理容器产品组合，以用于这些先进疗法。此外，美国食品药物管理局（FDA）等机构鼓励生物製造创新的监管支持也进一步推动了市场的成长。

此外，永续性和业务效率正在推动其应用，因为与传统系统相比，一次性容器可以减少水和能源消耗。製药公司面临最大程度减少环境足迹的压力，而SUBC透过消除清洗和灭菌的需求，有助于实现这一目标。随着生物製药管道的扩展以及製造商对灵活性的重视，在技术进步和不断变化的行业需求的支持下，美国生物处理容器市场预计将稳步增长。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国生物处理容器市场变数、趋势与范围

  • 市场展望
  • 渗透和成长前景图
  • 产业价值链分析
    • 原料趋势
    • 製造/技术趋势
  • 法律规范
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 商业环境分析
    • 波特五力分析
    • PESTEL分析

第四章美国生物加工容器市场：按产品分類的估计和趋势分析

  • 关键要点
  • 2024 年和 2033 年产品特定变化分析和市场占有率
    • 2D生物製程容器
    • 3D生物处理容器
    • 其他容器及配件

第五章美国生物处理容器市场：按应用的估计和趋势分析

  • 关键要点
  • 2024 年及 2033 年各应用领域的趋势分析及市场占有率
    • 上游流程
    • 下游工艺
    • 製程开发

第六章美国生物加工容器市场：按最终用途的估计和趋势分析

  • 关键要点
  • 2024 年和 2033 年按最终用途分類的趋势分析和市场占有率
    • 製药和生物製药公司
    • 委外研发机构和业务製造组织
    • 学术研究所
    • 其他的

第七章 竞争态势

  • 主要企业、最新发展及其对该产业的影响
  • 公司分类
  • 企业市场分析
  • 公司热图分析
  • 企业仪錶板分析
  • 战略地图
    • 扩张
    • 合併与收购
    • 合作
    • 新用途公告
    • 其他的

第八章 公司列表（公司概况、财务表现、应用概述）

  • Thermo Fisher Scientific Inc.
    • 公司简介
    • 财务表现
    • 应用程式基准
  • Merck
  • Saint-Gobain
  • Parker Hannifin Corp
  • Kiefel
  • Sartorius AG
  • CellBios
  • Entegris
  • Liquidyne Process Technologies, Inc.
  • Vonco Products, LLC
  • Anlagenbau GmbH
  • Avantor, Inc.
  • ILC Dover
Product Code: GVR-4-68040-635-4

U.S. Bioprocess Containers Market Summary

The U.S. bioprocess containers market size was estimated at USD 1.09 billion in 2024, and is projected to reach USD 6.55 billion by 2033, growing at a CAGR of 22.1% from 2025 to 2033. The industry is driven by the increasing adoption of single-use technologies in biopharmaceutical manufacturing and the growing demand for flexible, scalable solutions for biologics and vaccine production.

Additionally, strong R&D investments and supportive regulatory frameworks further accelerate market growth.The market is primarily driven by the rapid growth of the biopharmaceutical industry, particularly the increasing demand for monoclonal antibodies, cell and gene therapies, and vaccines. Single-use bioprocess containers (SUBCs) offer flexibility, cost-efficiency, and reduced contamination risks compared to traditional stainless-steel systems, making them ideal for modern biomanufacturing. For example, the surge in mRNA vaccine production during the COVID-19 pandemic highlighted the need for scalable, disposable solutions, with companies such as Pfizer and Moderna relying heavily on single-use technologies to accelerate production timelines.

Another key factor is the shift toward personalized medicine and small-batch production, which favors single-use systems due to their adaptability and lower operational costs. Cell and gene therapies, such as CAR-T cell treatments, require specialized, sterile environments that SUBCs can provide without extensive cleaning or validation. Companies such as Thermo Fisher Scientific Inc. and Sartorius AG have expanded their portfolios to include customizable bioprocess containers tailored for these advanced therapies. Additionally, regulatory support from agencies such as the FDA, which encourages innovation in biomanufacturing, further propels market growth.

Moreover, sustainability and operational efficiency are driving adoption, as single-use containers reduce water and energy consumption compared to traditional systems. Pharmaceutical companies are under pressure to minimize their environmental footprint, and SUBCs help achieve this by eliminating the need for cleaning and sterilization. As biopharmaceutical pipelines expand and manufacturers prioritize agility, the U.S. bioprocess containers market is expected to grow steadily, supported by technological advancements and evolving industry needs.

U.S. Bioprocess Containers Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. bioprocess containers market report based on product type, application, and end use:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • 2D U.S. Bioprocess Containers
  • 3D U.S. Bioprocess Containers
  • Other Containers & Accessories
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Upstream Processes
  • Downstream Processes
  • Process Developments
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Research Organizations & Contract Manufacturing Organizations
  • Academic & Research Institutes
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
    • 1.1.1. Market Segmentation
    • 1.1.2. Market Definition
  • 1.2. Research Scope & Assumptions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot, 2024 (USD Million)
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Bioprocess Containers Market Variables, Trends, and Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Raw Material Trends
    • 3.3.2. Manufacturing/Technology Trends
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Driver Analysis
    • 3.5.2. Market Restraint Analysis
    • 3.5.3. Market Opportunity Analysis
    • 3.5.4. Market Challenge Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL Analysis

Chapter 4. U.S. Bioprocess Containers Market: Product Type Estimates & Trend Analysis

  • 4.1. Key Takeaways
  • 4.2. Product Type Movement Analysis & Market Share, 2024 & 2033
    • 4.2.1. 2D Bioprocess Containers
      • 4.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.2.2. 3D Bioprocess Containers
      • 4.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.2.3. Other Containers & Accessories
      • 4.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Bioprocess Containers Market: Application Estimates & Trend Analysis

  • 5.1. Key Takeaways
  • 5.2. Application Movement Analysis & Market Share, 2024 & 2033
    • 5.2.1. Upstream Processes
      • 5.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.2. Downstream Processes
      • 5.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.3. Process Developments
      • 5.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Bioprocess Containers Market: End Use Estimates & Trend Analysis

  • 6.1. Key Takeaways
  • 6.2. End Use Movement Analysis & Market Share, 2024 & 2033
    • 6.2.1. Pharmaceutical & Biopharmaceutical Companies
      • 6.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. Contract Research Organizations & Contract Manufacturing Organizations
      • 6.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Academic & Research Institutes
      • 6.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Others
      • 6.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Key Players & Recent Developments & Their Impact on the Industry
  • 7.2. Company Categorization
  • 7.3. Company Market Position Analysis
  • 7.4. Company Heat Map Analysis
  • 7.5. Company Dashboard Analysis
  • 7.6. Strategy Mapping
    • 7.6.1. Expansions
    • 7.6.2. Mergers & Acquisitions
    • 7.6.3. Collaborations
    • 7.6.4. New Application Launches
    • 7.6.5. Others

Chapter 8. Company Listing (Overview, Financial Performance, Applications Overview)

  • 8.1. Thermo Fisher Scientific Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Application Benchmarking
  • 8.2. Merck
  • 8.3. Saint-Gobain
  • 8.4. Parker Hannifin Corp
  • 8.5. Kiefel
  • 8.6. Sartorius AG
  • 8.7. CellBios
  • 8.8. Entegris
  • 8.9. Liquidyne Process Technologies, Inc.
  • 8.10. Vonco Products, LLC
  • 8.11. Anlagenbau GmbH
  • 8.12. Avantor, Inc.
  • 8.13. ILC Dover

List of Tables

  • 1. U.S. Bioprocess Containers market estimates and forecasts, by Product Type, 2021 - 2033 (USD Million)
  • 2. U.S. Bioprocess Containers market estimates and forecasts, by 2D Bioprocess Containers, 2021 - 2033 (USD Million)
  • 3. U.S. Bioprocess Containers market estimates and forecasts, by 3D Bioprocess Containers, 2021 - 2033 (USD Million)
  • 4. U.S. Bioprocess Containers market estimates and forecasts, by Other Containers & Accessories, 2021 - 2033 (USD Million)
  • 5. U.S. Bioprocess Containers market estimates and forecasts, by Application, 2021 - 2033 (USD Million)
  • 6. U.S. Bioprocess Containers market estimates and forecasts, by Upstream Processes, 2021 - 2033 (USD Million)
  • 7. U.S. Bioprocess Containers market estimates and forecasts, by Downstream Processes, 2021 - 2033 (USD Million)
  • 8. U.S. Bioprocess Containers market estimates and forecasts, by Process Developments, 2021 - 2033 (USD Million)
  • 9. U.S. Bioprocess Containers market estimates and forecasts, by End Use, 2021 - 2033 (USD Million)
  • 10. U.S. Bioprocess Containers market estimates and forecasts, in Pharmaceutical & Biopharmaceutical Companies, 2021 - 2033 (USD Million)
  • 11. U.S. Bioprocess Containers market estimates and forecasts, in Contract Research Organizations & Contract Manufacturing Organizations, 2021 - 2033 (USD Million)
  • 12. U.S. Bioprocess Containers market estimates and forecasts, in Academic & Research Institutes, 2021 - 2033 (USD Million)
  • 13. U.S. Bioprocess Containers market estimates and forecasts, in Others, 2021 - 2033 (USD Million)

List of Figures

  • 1. Information Procurement
  • 2. Primary Research Pattern
  • 3. Primary Research Process
  • 4. Market Research Approaches - Bottom-Up Approach
  • 5. Market Research Approaches - Top-Down Approach
  • 6. Market Research Approaches - Combined Approach
  • 7. U.S. Bioprocess Containers Market- Market Snapshot
  • 8. U.S. Bioprocess Containers Market- Segment Snapshot (1/2)
  • 9. U.S. Bioprocess Containers Market- Segment Snapshot (2/2)
  • 10. U.S. Bioprocess Containers Market- Competitive Landscape Snapshot
  • 11. U.S. Bioprocess Containers Market: Penetration & Growth Prospect Mapping
  • 12. U.S. Bioprocess Containers Market: Value Chain Analysis
  • 13. U.S. Bioprocess Containers Market: Porter's Five Force Analysis
  • 14. U.S. Bioprocess Containers Market: PESTEL Analysis
  • 15. U.S. Bioprocess Containers Market: Product Type Movement Analysis, 2024 & 2033
  • 16. U.S. Bioprocess Containers Market: Application Movement Analysis, 2024 & 2033
  • 17. U.S. Bioprocess Containers Market: End Use Movement Analysis, 2024 & 2033
  • 18. U.S. Bioprocess Containers Market: Company Positioning Analysis
  • 19. U.S. Bioprocess Containers Market: Market Dashboard Analysis